Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Integrative Medicine

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2095-4964(15)60200-XPMID 26343106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application

  2015cited by this paper
• Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System

  2015cited by this paper
• Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides

  2014cited by this paper
• Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors

  2014cited by this paper
• Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities

  2014cited by this paper
• Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

  2014cited by this paper
• The prevalence of hemophilia in mainland China: a systematic review and meta-analysis.

  2014cited by this paper
• The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals

  2014cited by this paper
• Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo.

  2014cited by this paper
• Selective In Vivo Targeting of Human Liver Tumors by Optimized AAV3 Vectors in a Murine Xenograft Model

  2014cited by this paper
• Humoral Immune Response to AAV

  2013cited by this paper
• Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

  2013cited by this paper
• The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: Implications for gene therapy and vaccines using AAV1 vector

  2013cited by this paper
• Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions.

  2013cited by this paper
• The AAV vector toolkit: poised at the clinical crossroads.

  2012cited by this paper
• The AAV Vector Toolkit: Poised at the Clinical Crossroads.

  2012cited by this paper
• [Analysis of composite traditional Chinese medicine constitution: an investigation of 974 volunteers].

  2012cited by this paper
• Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

  2011cited by this paper
• Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

  2011cited by this paper
• [Stratified analysis of the relationship between traditional Chinese medicine constitutional types and health status in the general population based on data of 8,448 cases].

  2011cited by this paper
• Development of optimized AAV3 serotype vectors: Mechanism of high-efficiency transduction of human liver cancer cells

  2011cited by this paper
• Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

  2011cited by this paper
• Neutralizing antibodies against adeno‐associated viruses in inflammatory bowel disease patients: Implications for gene therapy

  2011cited by this paper
• [Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity].

  2010cited by this paper
• Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype 3

  2010cited by this paper
• Epidemiological investigation of constitutional types of Chinese medicine in general population: based on 21,948 epidemiological investigation data of nine provinces in China.

  2009cited by this paper
• Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

  2009cited by this paper
• Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.

  2008cited by this paper
• CD8+ T-cell responses to adeno-associated virus capsid in humans

  2007cited by this paper
• Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

  2006cited by this paper
• Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice

  2005cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice.

  1997cited by this paper
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

  1997cited by this paper
• Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults.

  1976cited by this paper
• Seroepidemiological and Ecological Studies of the Adenovirus-Associated Satellite Viruses

  1970cited by this paper
• Isolation of adenovirus-associated viruses from man.

  1967cited by this paper

• Retinal Epithelial Neutralization Assay Optimizes AAV Serotype Selection for Ocular Gene Therapy

  2025cites this paper
• Prevalence of Neutralizing Antibodies Against AAV Serotypes 2 and 9 in Healthy Participants from Multiple Centers Across China and Patients with DMD/BMD

  2024cites this paper
• Prevalence of Antibodies against Adeno-Associated Viruses (AAVs) in Göttingen Minipigs and Its Implications for Gene Therapy and Xenotransplantation

  2024cites this paper
• Seroprevalence of adeno-associated virus types 1, 2, 3, 4, 5, 6, 8, and 9 in a Basque cohort of healthy donors

  2024cites this paper
• An investigation of the immune epitopes of adeno-associated virus capsid-derived peptides among hemophilia patients

  2024cites this paper
• Understanding AAV vector immunogenicity: from particle to patient

  2024cites this paper
• Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans

  2023cites this paper
• Characterization of a Bioengineered AAV3B Capsid Variant with Enhanced Hepatocyte Tropism and Immune Evasion

  2023cites this paper
• Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure—ANVIAS Study

  2023cites this paper
• Association of traditional Chinese medicine body constitution and cold syndrome with leukocyte mitochondrial functions: An observational study

  2023cites this paper
• Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

  2022cites this paper
• A sensitive and drug tolerant assay for detecting anti-AAV9 antibodies using affinity capture elution.

  2022cites this paper
• Age‐stratified adeno‐associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India

  2022cites this paper
• Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma

  2021cites this paper
• Large-scale molecular epidemiological analysis of AAV in a cancer patient population

  2021cites this paper
• T Cell-Mediated Immune Responses to AAV and AAV Vectors

  2021cites this paper
• Optimization of AAV vectors to target persistent viral reservoirs

  2021cites this paper
• Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States

  2021cites this paper
• Directed Evolution of AAV Serotype 5 for Increased Hepatocyte Transduction and Retained Low Humoral Seroreactivity

  2020cites this paper
• Prevalence of Adeno-Associated Virus 3 Capsid Binding and Neutralizing Antibodies in Healthy and Hemophilia B Individuals from India

  2020cites this paper
• Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays

  2019cites this paper
• Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

  2019cites this paper
• TCM constitution yin deficiency affects treatment response of Peg-IFNα in patients with HBeAg-positive chronic hepatitis B and is related to HLA-DQA 1 gene polymorphisms

  2019cites this paper
• Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort

  2019cites this paper
• Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.

  2018cites this paper
• Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.

  2017cites this paper
• Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity

  2017cites this paper
• AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees

  2016cites this paper
• AAV natural infection induces broad cross-neutralizing antibody responses to multiple AAV serotypes in chimpanzees.

  2016cites this paper
• Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses

  2016cites this paper
• Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors

  2016cites this paper
• Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.

  2015cites this paper